Fig. 4: In vitro binding assay and cytotoxicity study. | Communications Chemistry

Fig. 4: In vitro binding assay and cytotoxicity study.

From: A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics

Fig. 4

a B-lymphoma cells were treated with NK20a, and the fluorescence of the treated cells was analyzed through flow cytometry to determine the binding ability of NK20a to the cell surface. The fluorescence distribution of FITC was categorized as treated with NK20a (green) and untreated (red). b Bar chart showing the cell viability of the B-lymphoma cell line treated with 10 ng/mL IL-10, 50 μg/mL NK20a, and both, respectively. Error bars represent the standard deviation of experiments done in triplicate.

Back to article page